STOCK TITAN

ALT5 Sigma Corporation 8-K Filings

ALTS NASDAQ

Every 8-K that ALT5 Sigma Corporation (ALTS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow ALTS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALTS filings page.

Rhea-AI Summary

AI Financial Corporation detailed how its WLFI token holdings improve its liquidity and ease prior going concern concerns. The company holds 6,905,276,644 WLFI tokens, with 3,321,690,994 tokens currently usable as collateral, for staking, or in lending transactions.

Based on a WLFI price of US$0.055, management estimates more than US$180 million in currently available digital assets and an aggregate WLFI market value of about US$380 million. Management believes this substantially strengthens its liquidity profile and that it has sufficient resources to fund anticipated operations and meet obligations for at least the next 12 months, substantially mitigating previously disclosed substantial doubt about its ability to continue as a going concern.

Rhea-AI Summary

AI Financial Corporation, formerly ALT5 Sigma Corporation, has officially changed its corporate name and Nasdaq ticker. The company’s name changed to AI Financial Corporation on April 28, 2026, and its common stock began trading under the new ticker AIFC on April 29, 2026.

The name change was completed through a short-form merger with a wholly owned Nevada subsidiary created solely for this purpose, with the parent company surviving. The company’s CUSIP number, transfer agent, and Frankfurt ticker 5AR1 remain the same, and trading on Nasdaq continues without interruption.

No action was required from stockholders for either the name change or the ticker change. Management describes the new identity as reflecting an ongoing evolution toward a broader financial platform focused on payments, tokenization, and AI-driven financial infrastructure built on systems that have processed more than $8 billion in cumulative transaction volume.

Rhea-AI Summary

ALT5 Sigma Corporation approved a new Employment Agreement for Tony Isaac and formally changed his title from Acting Chief Executive Officer to Chief Executive Officer. The agreement runs for three years with automatic annual renewals unless either party gives 90 days’ notice of non-renewal.

Mr. Isaac will receive an annual base salary of $600,000 and is eligible for a discretionary annual bonus determined by the Compensation Committee. He was also granted 5,000,000 shares of common stock as a Stock Award, with releases tied to the Company’s share price.

If his employment ends in specified circumstances, he is entitled to accrued compensation, potential bonus amounts, expense reimbursement, and full vesting of equity awards. Upon a termination in connection with a change of control, he may receive cash payments based on up to three times his base salary plus potential annual bonuses, and all restrictions on the Stock Award will be removed.

Rhea-AI Summary

ALT5 Sigma Corporation entered a Stock Exchange Agreement with the four owners of Block Street Corp., issuing 12,670,257 common shares valued at $12 million and granting two sets of five-year pre-funded warrants for up to 32,731,496 additional shares, both exercisable on a cashless basis.

The first warrant set vests after Block Street generates at least $20,000,000 in trailing four-quarter net revenues, and the second after $8,000,000 in trailing four-quarter Modified Operating Income. All shares issued or issuable are subject to a 24‑month lock-up with volume-based leak-out limits.

ALT5 Sigma also signed a binding letter of intent to acquire Dectec, issuing 4,000,000 shares at closing and up to 4,000,000 additional shares over 36 months, at 1,000,000 shares for every $5,000,000 of Gross Profit generated by Dectec’s solutions.

Rhea-AI Summary

ALT5 Sigma Corporation described how it resolved three Nasdaq listing compliance issues. The company had previously received notices for not timely filing its Form 10-Q for the period ending September 27, 2025, for having an audit committee vacancy, and for not holding an annual stockholders’ meeting within 12 months of its fiscal year-end.

The company filed the delayed Form 10-Q on January 12, 2026, after which Nasdaq confirmed on January 13, 2026 that it was back in compliance with Listing Rule 5250(c)(1). ALT5 Sigma then appointed Tim Stanley as an independent director and Audit Committee Chair on February 6, 2026, and Nasdaq confirmed on March 3, 2026 that the audit committee requirement under Listing Rule 5605(c)(2)(A) was satisfied. Finally, after holding its 2025 Annual Meeting of Stockholders on February 27, 2026, Nasdaq notified the company on March 3, 2026 that it complied with the annual meeting requirement under Listing Rule 5620(a), closing all three matters.

Rhea-AI Summary

ALT5 Sigma Corporation reported the results of its 2025 Annual Meeting of Stockholders held on February 27, 2026. Shareholders elected all nominated directors, including Zachary Witkoff, Tony Isaac, Zachary Folkman, Nael Hajjar, John Bitar, Dr. Adel Elmessiry, and Tim Stanley, each for a one-year term.

Support for the nominees was strong, with most receiving around 29.5 million votes for and relatively few votes withheld. Stockholders also ratified L J Soldinger Associates, LLC as the independent registered public accounting firm for fiscal 2025 with 52,739,070 votes for, 2,022,767 against, and 91,016 abstentions.

In addition, shareholders approved a proposal to adjourn the Annual Meeting if necessary, with 49,839,502 votes for, 4,851,349 against, and 162,002 abstentions. Tony Isaac, acting chief executive officer, signed the report on behalf of the company.

Rhea-AI Summary

ALT5 Sigma Corporation filed an 8-K after Acting CEO Tony Isaac issued a detailed letter to stockholders. He reports that ALT5 has restored compliance with U.S. SEC reporting obligations and regained compliance with applicable Nasdaq listing requirements, while reorganizing operations and enhancing investor outreach.

The letter highlights governance changes, including replacing the prior CFO/acting CEO, appointing Steven Plumb as CFO, and adding two new directors. It also updates a Rwanda court case involving approximately US$3.5 million; ALT5 has already recorded a US$3.5 million allowance, so an unsuccessful appeal would not further affect its financial statements.

Management estimates net asset value at about $843 million, or $6.67 per share, compared with a roughly $192 million equity market capitalization at a $1.52 share price as of February 19, 2026, and notes a previously authorized share repurchase program. ALT5 says it has processed more than $8 billion in digital asset transactions and recently launched the ALT5 Ai unit to extend its regulated payments and settlement infrastructure into AI-driven commerce.

Rhea-AI Summary

ALT5 Sigma Corporation appointed Tim Stanley as an independent director on January 30, 2026, and added him to its Audit Committee effective immediately. The board determined he meets Nasdaq independence standards and the financial literacy requirements of Rule 10A-3 under the Exchange Act.

The company had received a Nasdaq notice on December 3, 2025 for non-compliance with Listing Rule 5605(c) following director resignations, and states that Mr. Stanley’s appointment restored compliance within the allowed cure period. The filing highlights his three decades of senior leadership and extensive public-company board and audit committee experience.

Rhea-AI Summary

ALT5 Sigma Corporation reported that its Board appointed Dr. Adel ElMessiry as an independent director. The Nominating and Corporate Governance Committee recommended him on January 26, 2026, and he accepted the appointment on January 29, 2026. The Board determined he meets Nasdaq’s independence requirements.

Dr. ElMessiry co-founded AlphaFin, a fintech company focused on decentralized and blockchain-powered financial systems, and serves as its President and Chief Technology Officer. He also holds roles with Lussa in Dubai, the Nashville Entrepreneur Center, and WebDBTech, and previously held senior technology leadership positions in healthcare-related organizations. The company states there are no related-party transactions or new material compensation arrangements tied to his appointment.

Rhea-AI Summary

ALT5 Sigma Corporation entered into a Master Loan and Security Agreement providing a collateralized loan facility of $15 million to its subsidiary ALT5 Digital Holdings. The loan bears interest at 4.50% per year, paid annually in advance, and matures 24 months after the initial closing.

The facility is non-recourse to the borrower beyond pledged $WLFI tokens, secured by a loan-to-value ratio of 65%, implying about $23 million in WLFI token collateral for a full draw. ALT5 Digital has already drawn the entire $15 million, receiving net proceeds of approximately $14.2 million after prepaid interest and expenses.

The company plans to use the funds for a board-approved stock buyback program, purchasing additional $WLFI tokens, and general corporate purposes. The transaction is a related-party arrangement because Board Chairman Zachary Witkoff is CEO and Co-Founder of WLFI and director Zachary Folkman is a Co-Founder of WLFI.

Rhea-AI Summary

ALT5 Sigma Corporation appointed Steven M. Plumb as Chief Financial Officer, principal financial officer and principal accounting officer, effective November 24, 2025, and later finalized his employment agreement on January 21, 2026.

The agreement provides a $339,400 annual base salary, eligibility for an annual bonus equal to 50% of base salary, and a $20,000 signing bonus paid to Clear Financial Solutions. Plumb also received 95,337 restricted stock units under the 2024 Equity Incentive Plan, with half vesting on the first anniversary of his start date and the rest vesting quarterly over the following year.

If the company terminates him without cause or he resigns with good reason, he is entitled to one year of continued base salary, payment of any earned but unpaid bonuses, a prorated bonus for the year of termination in certain cases, and accelerated vesting treatment for his equity awards, subject to a release of claims.

Rhea-AI Summary

ALT5 Sigma Corporation reached a comprehensive settlement with Wellington Peel, LLC and related parties, resolving previously disclosed litigation and related disputes. As part of the agreement, all parties granted mutual releases of claims connected to those matters, and the earlier court action was withdrawn without prejudice.

To resolve a contractual dispute over a terminated consulting agreement, ALT5 Sigma agreed to pay Wellington Peel, LLC a total of $200,000, with $100,000 due at signing and $20,000 in five monthly installments starting in February 2026. The company will also issue 225,000 shares of common stock to Wellington Peel, LLC and its principal, and 50,000 shares to a former employee of its Canadian subsidiary in connection with a share award dispute. The settlement includes no admission of liability by any party, and ALT5 Sigma states it does not expect a material impact on its financial condition, results of operations, or cash flows.

Rhea-AI Summary

ALT5 Sigma Corporation entered into a Separation Agreement and Mutual Release of Claims with former Chief Executive Officer Peter Tassiopoulos, under which his employment with the company and its affiliates, and his August 26, 2024 employment agreement, will conclude on December 15, 2025.

The company will pay him all salary and wages due and owing through that separation date, described as "Past Due Compensation," and after this payment it will have no further economic, compensatory or benefit related obligations to him. Both sides mutually release claims with no reference to or admission of wrongdoing. Mr. Tassiopoulos will also resign from the board of directors effective December 15, 2025, while agreeing to remain available for transition assistance, and the report is signed by Acting Chief Executive Officer Tony Isaac.

Rhea-AI Summary

ALT5 Sigma Corporation appointed Victor Mokuolo, CPA PLLC as its new independent registered public accounting firm, effective December 8, 2025, for the fiscal year ending December 27, 2025.

The company states that during its two most recent fiscal years ended December 28, 2024 and December 30, 2023, and through December 8, 2025, it did not consult this firm on accounting principles, audit opinions, or other accounting matters, and there were no disagreements or reportable events of the type described in the relevant SEC disclosure items.

Rhea-AI Summary

ALT5 Sigma Corporation announced several leadership changes and a board update. The Board ended the employment of Jonathan Hugh as Chief Financial Officer and Acting Chief Executive Officer, and plans to finalize his departure terms later. The company also notified Chief Operating Officer Ron Pitters that his consulting agreement will end in accordance with its terms, after which he will no longer serve as COO, though he remains on the Board.

The Board appointed Tony Isaac, already President and a director, as Acting Chief Executive Officer and designated him as principal executive officer, while he continues in his existing roles. The company also named Steven Plumb as Chief Financial Officer and principal accounting officer; under his offer, he will receive a base annual salary of $339,400, and the company expects to enter into a formal employment agreement with him. Director David Danziger resigned from the Board and its committees for personal reasons and not due to any disagreement with the company.

The Board passed a resolution to disband its Special Committee, which had been created to investigate certain matters previously disclosed. The facts and issues reviewed by the Special Committee and its advisors were presented to the full Board so it can continue to act in accordance with its fiduciary duties to shareholders.

Rhea-AI Summary

ALT5 Sigma Corporation reported that it will not file its Quarterly Report on Form 10-Q for the quarter ended September 27, 2025 on time because it has not completed its review and reporting of those financial results. The company states that the delay arises from several factors, including issues it has previously described. ALT5 Sigma plans to update stockholders once it has more information about filing its third-quarter 2025 financial results and any related previously issued financial statements.

Rhea-AI Summary

ALT5 Sigma Corporation announced a leadership change. On October 16, 2025, the Board suspended Peter Tassiopoulos and removed his duties as Chief Executive Officer, effective immediately and with pay. The company appointed Jonathan Hugh to assume those duties as Acting Chief Executive Officer. Hugh will continue in his current role while carrying these additional responsibilities.

This update reflects a governance action under Item 5.02. The company lists its common stock on The Nasdaq Stock Market under the symbol ALTS. The filing was signed by Acting Chief Executive Officer and Chief Financial Officer Jonathan Hugh.

Rhea-AI Summary

ALT5 Sigma Corporation reported that stockholders approved an amendment to increase authorized common stock from 200,000,000 to 2,000,000,000 shares. The vote at the reconvened Special Meeting on October 16, 2025 passed with 56,829,178 votes for, 13,099,874 against, and 4,646 abstentions. The company plans to file the amendment with the Secretary of State of Nevada.

As context, there were 109,620,596 shares of common stock outstanding and 883,667 shares of voting preferred stock outstanding as of August 12, 2025, the record date. No other matters were voted on at the reconvened Special Meeting.

Rhea-AI Summary

ALT5 Sigma Corporation disclosed a targeted update to prior token restrictions tied to its August 11, 2025 agreements with World Liberty Financial. The company obtained a limited waiver allowing $WLFI tokens to be pledged as collateral, lent, and staked (to the extent permitted by World Liberty Financial), while dispositions and sales remain restricted.

For tokens purchased under the Securities Purchase Agreement, this waiver applies only when prefunded warrants are exercisable in full and all related securities have an effective resale registration statement. Exercisability depends on an increase in authorized share capital, which requires shareholder approval. All other Token Prohibitions remain in effect.

Rhea-AI Summary

ALT5 Sigma Corporation reported voting results from its Special Meeting held virtually on October 10, 2025. Stockholders voted on Proposal 1, Proposal 2, and Proposal 4. The meeting was adjourned for Proposal 3, which seeks to amend the Articles of Incorporation to increase authorized common stock from 200,000,000 to 2,000,000,000; the meeting will resume on October 16, 2025 at 1:00 p.m. Eastern Time at www.virtualshareholdermeeting.com/ALTS2025SM.

For Proposal 1 (issuance of 119,000,000 shares of common stock upon exercise of pre-funded and common stock purchase warrants held by World Liberty Financial, Inc., under the August 11, 2025 securities purchase agreement), votes were For 36,989,693; Against 12,381,062; Abstentions 6,427; Broker Non-Votes 13,867,952. For Proposal 2 (appointment of a second director selected by World Liberty Financial, Inc.), votes were For 25,091,099; Against 23,868,657; Abstentions 417,426; Broker Non-Votes 13,867,952. For Proposal 4 (approval of adjournments/postponements), votes were For 24,506,210; Against 24,464,260; Abstentions 406,712; Broker Non-Votes 13,867,952. As of August 12, 2025, outstanding shares were 109,620,596 common and 883,667 voting preferred.

Rhea-AI Summary

ALT5 Sigma Corporation filed an 8-K to furnish two recent press releases. On October 6, 2025, the company issued a release highlighting recent advancements in its $WLFI digital asset ecosystem, which is part of its digital asset treasury operations. On October 8, 2025, it issued a second release containing a letter to stockholders related to the upcoming Special Meeting of Stockholders on October 10, 2025.

The company emphasizes that this information is being furnished, not filed, meaning it is not subject to certain Exchange Act liabilities and is not automatically incorporated into other SEC filings. The report includes a detailed cautionary note that many statements about growth in digital asset treasury operations, adoption and trading of $WLFI tokens, and platform profitability are forward-looking and subject to risks described in its prior Form 10-K and Form 10-Q.

Rhea-AI Summary

ALT5 Sigma Corporation is updating investors on its previously announced plan to separate into two companies and finance Alyea Therapeutics Corporation independently. A planned spin-off or similar transaction of Alyea will not take place using the earlier disclosed June 2, 2025 record date and may not occur under the previously communicated timeline. The Company states that, if it proceeds with a spin-off or similar transaction, it will later announce details such as a new record date, structure, and timing. ALT5 Sigma highlights its continued confidence in Alyea’s non-addictive pain treatment patents and potential progression to the next stage of clinical trials, and notes that it is continuing to evaluate strategic options to maximize and realize Alyea’s value.